rediff.com

NewsApp (Free)

Read news as it happens
Download NewsApp

Available on  

Rediff News  All News 

Janssen Pharmaceuticals

Rediff.com  »  News  »   Janssen Pharmaceuticals

  News for Janssen Pharmaceuticals

  • Business

India could be 'efficacy test' for TB drug okayed by US

Experts tracking the treatment of TB are excited about the TB drug, but warn of the unregulated use of drugs in India leading to growing incidence of drug resistance Sirturo, the bedaquiline drug......

Sun Pharma gets USFDA nod for anti-cancer injection

Sun Pharmaceutical Industries on Tuesday said it has received US health regulator's approval to market generic version of Doxil injection, used in treating ovarian cancer in the American market.......

Sunset for profitable drug window in US

Advantage Johnson & Johnson (J&J) could mean loss for Sun Pharma. The Mumbai-based drug maker might soon have to stop exporting its cancer drug, Lipodox, to the US, as J&J is preparing a comeback......

US oral contraceptive market draws Indian pharma

Indian pharmaceutical companies, which always wanted a big share in the global copycat drug market, are betting high on the oral contraceptive (OC) market in America.Apart from Glenmark, Sun......

Glenmark gets nod for oral contraceptive tablets

Glenmark Pharmaceuticals on Monday said its US subsidiary Glenmark Generics Inc has received US health regulator's approval to market its generic oral contraceptives Norgestimate and Ethinyl......
  Web results for Janssen Pharmaceuticals
Dilated Cardiomyopathy Therapeutics Market - Global Industry Analysis, Pipeline Analysis, Size, Share, Growth,..

/PRNewswire/ -- Dilated cardiomyopathy is an important cause of heart failure and is one of the leading indications for heart transplantation... ...

http://in.advfn.com/p.php?pid=nmona&article=66547628
Janssen India launches diabetes treatment drug

NEW DELHI: Janssen, the pharmaceutical division of Johnson & Johnson, today launched Invokana, a new diabetes treatment medication in India.... ...

http://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/janssen-india-launches-diabetes-treatment-drug/articleshow/47029686.cms
Quotient Clinical completes innovative first-in-human program

Quotient Clinical, the Translational Pharmaceutics® Company, has announced the publication of results from an Enabled-First-in-Human (Enabled-FIH)... ...

http://pressreleaseping.com/quotient-clinical-completes-innovative-first-human-program
Janssen Announces SVR12 Rates with Twelve Weeks of Treatment with All-Oral, Once-Daily Regimen of Simeprevir Plus Sofosbuvir in Genotype 1 HCV Patients With and Without Cirrhosis

From the Wires - Data from OPTIMIST-1 and OPTIMIST-2 Trials Showing SVR12 Rates of 97 Percent and 84 Percent to be Presented at The International... ...

http://in.sys-con.com/node/3328658
Novartis delivered sales growth (cc), significant margin expansion (cc) and strong innovation in Q1[1]; now with a more focused portfolio

· *Continuing* *operations[1] saw sales, core[2] operating income and core EPS grow (cc[2]) in Q1* · Net sales were USD 11.9 billion (-7%, +3%... ...

http://newsr.in/n/Press+Releases/754zwr0sp/Novartis-delivered-sales-growth-cc-significant-margin.htm

Related Tags


  1. gujarat
  2. bjp
  3. india
  4. lok sabha
  5. supreme court
  6. upa
  7. bharatiya janata party
  8. congress
  9. new delhi
  10. united progressive alliance
  11. ahmedabad
  12. sonia gandhi
  13. nda
  14. rahul gandhi
  15. rajnath singh
  16. nitin gadkari
  17. delhi
  18. manmohan singh
  19. bihar
  20. national democratic alliance
  21. jd-u
  22. nitish kumar
  23. rashtriya swayamsevak sangh
  24. uttar pradesh
  25. photo
  26. advani
  27. central bureau of investigation
  28. rss
  29. janata dal-united
  30. ips

Top Coverage News


Coming to India and making

Success in manufacturing is not just about being cheap - cheap labour, cheap land, cheap power...
Broswe by: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z